In prostate adenocarcinoma, although high levels of FMRP correlate with poor prognosis, its down-regulation might also be linked to disease progression, indicating that FMRP could play a tumor-suppressive role in the early stages of cancer. The gene discussed is FMR1; the disease is cancer.